John Todd Mitchell Sells 159,556 Shares of PACS Group (NYSE:PACS) Stock

PACS Group, Inc. (NYSE:PACSGet Free Report) insider John Todd Mitchell sold 159,556 shares of PACS Group stock in a transaction dated Monday, November 24th. The stock was sold at an average price of $29.89, for a total transaction of $4,769,128.84. Following the sale, the insider owned 755,836 shares of the company’s stock, valued at approximately $22,591,938.04. This trade represents a 17.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

PACS Group Trading Up 0.9%

NYSE:PACS traded up $0.28 on Wednesday, hitting $32.06. 1,278,920 shares of the stock were exchanged, compared to its average volume of 840,949. The stock has a market cap of $5.02 billion, a PE ratio of 30.53 and a beta of 1.05. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.28. PACS Group, Inc. has a fifty-two week low of $7.50 and a fifty-two week high of $32.60. The stock has a fifty day moving average of $14.11 and a 200-day moving average of $12.33.

PACS Group (NYSE:PACSGet Free Report) last announced its earnings results on Wednesday, November 19th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.14). The company had revenue of $1.28 billion for the quarter, compared to analysts’ expectations of $1.11 billion. PACS Group had a net margin of 3.29% and a return on equity of 21.39%. PACS Group has set its FY 2025 guidance at EPS. As a group, equities analysts expect that PACS Group, Inc. will post 1.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on PACS. Weiss Ratings raised PACS Group from a “sell (d)” rating to a “hold (c-)” rating in a report on Thursday, November 20th. Royal Bank Of Canada upped their price target on shares of PACS Group from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Thursday, November 20th. Finally, Wall Street Zen raised PACS Group from a “hold” rating to a “buy” rating in a research report on Saturday. Three investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, PACS Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $26.75.

View Our Latest Report on PACS Group

Institutional Trading of PACS Group

Several hedge funds have recently added to or reduced their stakes in PACS. Quarry LP raised its stake in shares of PACS Group by 79.5% during the 3rd quarter. Quarry LP now owns 2,388 shares of the company’s stock worth $33,000 after purchasing an additional 1,058 shares in the last quarter. Strategic Advocates LLC bought a new stake in PACS Group during the 3rd quarter worth approximately $60,000. Jones Financial Companies Lllp bought a new stake in PACS Group in the first quarter valued at approximately $64,000. State of Alaska Department of Revenue acquired a new position in shares of PACS Group in the 3rd quarter valued at about $69,000. Finally, Tower Research Capital LLC TRC raised its holdings in shares of PACS Group by 289.0% during the second quarter. Tower Research Capital LLC TRC now owns 6,166 shares of the company’s stock valued at $80,000 after purchasing an additional 4,581 shares during the period.

PACS Group Company Profile

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Read More

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.